Clinical Trial: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HS-10561 Capsule in Healthy Chinese Adults and Patients With Chronic Spontaneous Urticaria.

U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864507) titled 'A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HS-10561 Capsule in Healthy Chinese Adults and Patients With Chronic Spontaneous Urticaria.' on March 04.

Brief Summary: This is a randomized, double-blind, placebo-controlled phase 1/2 clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of HS-10561 capsule in healthy Chinese adults and patients with chronic spontaneous urticaria.

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Chronic Spontaneous Urticaria

Intervention: DRUG: HS-10561

Single and multiple doses of HS-10561 oral...